NCT02745158 The Fibrodysplasia Ossificans Progressiva (FOP) Registry
| NCT ID | NCT02745158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The International FOP Association |
| Condition | Fibrodysplasia Ossificans Progressiva (FOP) |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2015-07 |
| Primary Completion | 2035-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2015-07 with a primary completion date of 2035-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. A physician portal (in development) will allow physicians to enter clinical data about their patients. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.
Eligibility Criteria
Inclusion Criteria: * Participants must have a confirmed diagnosis of FOP. * Participants (or a parent or legal guardian) must be willing and able to provide written informed consent. Exclusion Criteria: * There are no exclusion criteria.
Contact & Investigator
Mark Hamilton, PhD
STUDY DIRECTOR
International Fibrodysplasia Ossificans Progressiva Association
Frequently Asked Questions
Who can join the NCT02745158 clinical trial?
This trial is open to participants of all sexes, studying Fibrodysplasia Ossificans Progressiva (FOP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02745158 currently recruiting?
Yes, NCT02745158 is actively recruiting participants. Contact the research team at mark.hamilton@ifopa.org for enrollment information.
Where is the NCT02745158 trial being conducted?
This trial is being conducted at North Kansas City, United States.
Who is sponsoring the NCT02745158 clinical trial?
NCT02745158 is sponsored by The International FOP Association. The principal investigator is Mark Hamilton, PhD at International Fibrodysplasia Ossificans Progressiva Association. The trial plans to enroll 800 participants.